SOLIGENIX, INC. — Director's Dealing 2007

Aug 29, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2007-08-28

Reporting Person: SCHABER CHRISTOPHER J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-28	Common Stock	P	100000	$.2906	Acquired	392766	Direct